View Older Stories View More Recent Stories

Feb 10, 2025 10:00AM This pharma stock offers 'best-in-class catalyst path': Goldman Sachs
Feb 10, 2025 05:32AM AstraZeneca (AZN:LN) (AZN) PT Lowered to GBP150.67 at Goldman Sachs
Feb 9, 2025 07:35AM Faruqi & Faruqi Reminds AstraZeneca Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 21, 2025 - AZN
Feb 8, 2025 01:32PM ROSEN, LEADING TRIAL ATTORNEYS, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important February 21 Deadline in Securities Class Action First Filed by the Firm - AZN
Feb 7, 2025 12:12PM ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important February 21 Deadline in Securities Class Action First Filed by the Firm - AZN
Feb 6, 2025 05:42PM DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca
Feb 6, 2025 05:14AM AstraZeneca (AZN) Tops Q4 EPS by 103c; offers guidance
Feb 3, 2025 06:47PM ROSEN, A LEADING LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Feb 3, 2025 05:48PM SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca
Jan 28, 2025 02:22PM AstraZeneca (AZN) Reels from China Investigation and Investor Suit- Hagens Berman
Jan 28, 2025 03:14AM Berenberg Reiterates Buy Rating on AstraZeneca (AZN:LN) (AZN), Pipeline valuation gap looks compelling
Jan 27, 2025 12:57PM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca
Jan 26, 2025 07:42AM ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca
Jan 23, 2025 05:06PM ROSEN, A LONGSTANDING LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 23, 2025 02:18PM AstraZeneca (AZN) plans C$820 million (US$570m) investment in Canada to advance growing global hub and clinical delivery
Jan 22, 2025 05:01PM ROSEN, TRUSTED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 21, 2025 03:55PM AstraZeneca (AZN) Faces Securities Class Action After Reports of PRC Probe into Fraud and Corruption - Hagens Berman
Jan 21, 2025 09:48AM Faruqi & Faruqi Reminds AstraZeneca Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 21, 2025 - AZN
Jan 20, 2025 02:16PM ROSEN, NATIONAL INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 19, 2025 12:03PM ROSEN, SKILLED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 19, 2025 07:53AM DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca
Jan 17, 2025 08:45PM AZN INVESTOR ALERT: AstraZeneca PLC Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
Jan 17, 2025 05:03PM ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 17, 2025 07:16AM AstraZeneca (AZN:LN) (AZN) PT Raised to GBP13,100 at Guggenheim
Jan 17, 2025 07:00AM AstraZeneca (AZN) Reports CALQUENCE plus chemoimmunotherapy approved in the US for patients with previously untreated mantle cell lymphoma
Jan 16, 2025 04:58PM ROSEN, LEADING INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 15, 2025 04:53PM ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 14, 2025 04:48PM ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 14, 2025 04:23PM AstraZeneca (AZN) Faces Securities Class Action After Reports of PRC Probe into Fraud and Corruption - Hagens Berman
Jan 13, 2025 04:47PM ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 13, 2025 06:09AM AstraZeneca (AZN) Reports Datopotamab Deruxtecan Granted Priority Review in the U.S. for Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer
Jan 12, 2025 04:47PM ROSEN, A HIGHLY-REGARDED LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 12, 2025 09:14AM DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca
Jan 11, 2025 04:47PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 9, 2025 10:45PM DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca
Jan 9, 2025 07:11PM ROSEN, SKILLED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 8, 2025 07:06PM ROSEN, NATIONAL TRIAL LAWYERS, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 7, 2025 07:05PM ROSEN, A LONGSTANDING FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 7, 2025 11:00AM TD Cowen on Pharma: '10 Events in 2025 That Could Change Practice, Alter Companies, Move Stocks'
Jan 5, 2025 10:06PM ROSEN, A LEADING LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 5, 2025 09:50AM AZN INVESTOR ALERT: AstraZeneca PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jan 4, 2025 10:05PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 4, 2025 12:45PM SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca
Jan 3, 2025 10:05PM ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 3, 2025 07:18AM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca
Jan 2, 2025 10:04PM ROSEN, A RANKED AND LEADING FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 2, 2025 04:00PM AZN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AstraZeneca PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jan 2, 2025 12:48PM AstraZeneca (AZN) Reels from China Investigation and Investor Suit- Hagens Berman
Jan 2, 2025 12:39PM TD Cowen on Trump Tariffs and Other Risks: 'Where Does Pharma Stand?'
Jan 1, 2025 10:03PM ROSEN, SKILLED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
View More Recent Stories View Older Stories